Fares Al-Ejeh

14PUBLICATIONS
71CO-AUTHORS
Molecular targetsGlobal Indigenous studies health and wellbeingPredictive and prognostic markersRespiratory diseasesTissue engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|May 27, 2026
EZH2-Associated Hypermethylated Gene Signature Predicts Immunotherapy Response and Implicates DUSP5 in Tumor-Immune Regulation in Triple-Negative Breast Cancer.

|Nov 07, 2024
EphA2 regulates vascular permeability and prostate cancer metastasis via modulation of cell junction protein phosphorylation.

Carolin Offenhäuser, Keyur A Dave, Kirrilee J Beckett

|Sep 21, 2023
Cancer Incidence and Mortality Estimates in Arab Countries in 2018: A GLOBOCAN Data Analysis.

Mariam Al-Muftah, Fares Al-Ejeh

|May 02, 2022
Epigenome erosion and SOX10 drive neural crest phenotypic mimicry in triple-negative breast cancer.

Jodi M Saunus, Xavier M De Luca, Korinne Northwood

|Feb 18, 2022
Prognostic tools and candidate drugs based on plasma proteomics of patients with severe COVID-19 complications.

Maryam A Y Al-Nesf, Houari B Abdesselem, Ilham Bensmail

|Feb 16, 2021
G9a Inhibition Enhances Checkpoint Inhibitor Blockade Response in Melanoma.

Gregory M Kelly, Fares Al-Ejeh, Robert McCuaig

Pageof 3

Frequent Collaborators

3 joint publications

Priyakshi Kalita-de Croft

2 joint publications

Mariam Al-Muftah

2 joint publications

Jamie R Kutasovic

2 joint publications

Jodi M Saunus